biomedicina slovenica

re="EUR HEART J" : 48

  1. Comin-Colet J; Lainščak Mitja; Dickstein K; Filippatos GS; Johnson P; Luscher TF; Mori C; Willenheimer R; Ponikowski P; Anker SD
    The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
    2013 ►
  2. Camm AJ; Kirchhof P; Lip GY; Zupan I
    Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    2010 ►
  3. Tendera Michal; Aboyans Victor; Bartelink Marie-Louise; Blinc Aleš
    ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task Force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC)
    2011 ►
  4. Podbregar Matej; Gabrijelčič Tone
    Acute right heart overload due to pulmonary artery obstruction caused by ruptured aortic dissection
    2011 ►
  5. Edelmann F; Wachter R; Lainščak M; Tahirovič E
    Beta-blockers in elderly patients differentially affect symptoms and myocardial function in systolic vs. diastolic feart failure: results from the CIBIS-ELD
    2010 ►
  6. Comin-Colet J; Lainščak M; Dickstein K; Filippatos G
    Intravenous ferric carboxymaltose improves quality of life in patients with chronic heart failure and iron deficiency regardless the presence of anemia: an analysis from the FAIR-HF study
    2010 ►
  7. Lainščak M; Inkrot S; Farkaš J; Tahirovič E
    Self-rated health during beta-blocker titration in elderly patients with heart failure: the CIBIS-ELD analysis
    2010 ►
  8. Blinc A; Kozak M; Šabovič M; Božič M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
    Prevention of ischaemic events in patients with peripheral arterial disease according to the European guidelines on cardiovascular disease prevention in practice
    2009 ►
  9. Lainščak Mitja; Anker Stefan D; Cleland John G
    Smoking cessation in heart failure: easier said than done
    2009 ►
  10. Sinkovič A; Šuran D; Lokar L; Fliser E; Škerget M; Novak Z; Knez Z
    The effect of rosemary extracts on endothelial function and plasma PAI-1 activity
    2008 ►
  11. Doehner W; Von Haehling S; Rauchhaus M; Lainščak M; Habedank D; Sandek A; Szabo T; Anker SD
    Inferiority of single assessment derived estimates of insulin sensitivity for metabolic studies in patients with chronic heart failure
    2008 ►
  12. Doehner W; Karhausen T; Kennecke C; Todorović J; Rauchhaus M; Sandek A; Lainščak M; Von Haehling S; Anker SD
    The impact of irbesartan on impaired insulin sensitivity in chronic heart failure - results from a placebo-controlled, double blinded, randomized proof of concept-trial
    2008 ►
  13. Lainščak M; Hodošček-Majc L; Von Haehling S; Doehner W; Anker SD
    Antithrombotic drugs in patients with chronic heart failure
    2008 ►
  14. Filippatos GS; Lainščak M; Adamopoulos C; Wahle C; Kremastinos DT; Ahmed A
    Gender-related variations in the natural history of chronic heart failure: a propensity-matched study
    2008 ►
  15. Lainščak M; Števančec D; Hodošček L; Balažic-Gjura A
    Symptoms and quality of life in heart failure: assessment by patient, nurse and doctor
    2007 ►
  16. Lainščak M; Anker SD; von Haehling S; Ponikowski P; Libhaber C; Sliwa K
    Pentoxifzlline increases hemoglobin in anemic patients with chronic heart failure
    2007 ►
  17. Haehling SV; Lainščak M; Anker SD
    Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
    2007 ►
  18. Lopez-Sendon J; Lainščak M
    Recommendations on sub-speciality accreditation in cardiology: the coordination task force on sub-speciality accreditation of the European board for the speciality of cardiology
    2007 ►
  19. Vrtovec B; Goličnik A; Ferjan M; Bunc M
    Predictors of outcome in patients with anemia and advanced heart failure
    2006 ►
  20. Lainščak M; Von Haehling S; Sandek A; Keber I; Kerbev M; Anker SD
    Predictive value of short-term weight loss afterhospitalization and lomg-term survival in patients with chronic heart failure
    2006 ►
  21. Žižek B; Poredoš P; Videčnik V
    Endothelial dysfunction and morphologic arterial wall abnormalities in essential hypertension
    1997 ►
  22. Žižek B; Trojar A; Željko T; Poredoš P
    Impact of insulin resistance on left venticular diastolic function in normotensive offspring of subjects with essential hypertension
    2005 ►
  23. Zupan I; Mueller H; Marte W; Kahn JM; Schrader J; Tscheliessnigg KH
    Implant-based cardiac ischaemia monitoring: which electrode configuration is the best?
    2005 ►
  24. Lainščak Mitja; Keber I; Anker SD
    Initation of treatment with carvedilol or bisoprolol and changes in body fat mass in patients with chronic heart failure
    2005 ►
  25. Lainščak Mitja; Keber I; Lenzen MJ; Follath F; Swedberg K; Komajda M; Cleland JGF
    Inadequate recall of advice on diet and lifestyle in patients with heart failure: experience from the Euro heart failure survey
    2005 ►
  26. Lainščak Mitja; Komajda M; Keber I; Lenzen MJ; Follath F; Swedberg K; Cleland JGF
    Advice on non-pharmacological measures to patients after hospitalisation for heart failure is insufficient: experience from the European failure survey
    2005 ►
  27. Lainščak M; Cleland JGF; Lenzen M; Follath F; Komajda M; Swedberg K
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the Euro heart failure survey
    2005 ►
  28. Vokač D; Gradišer B; Veble A
    An attempt to determine ventricular insertion site of accessory atrio - venticular connection in patients with WPW syndrome with use of inverse reconstruction protocol from the data of body surface ECG chest leads
    1993 ►
  29. Grošelj C; Kukar M; Fettich J; Kononenko I
    Artificial intelligence improves the accuracy of coronary artery disease diagnostic methods
    1997 ►
  30. Ravnik J; Podlesnik M; Koželj M; Markovič S; Osredkar J
    The relationship between tumor markers and echocardiographic findings in carcinoid heart disease
    2002 ►
  31. Kranjec I; Cijan A; Jasnić D; Zorman D; Starc R; Janežič A
    Evolution of coronary lesions in unstable angina pectoris
    1988 ►
  32. Šebeštjen M; Keber I; Žegura B; Simšič S; Fressart M; Stegnar M
    Better influence of statin than of fibrate on novel risk factors in combined hyperlipidemia
    2002 ►
  33. Maver J; Štrucl M; Accetto R; Derganc Franc
    Activity of autonomic nervous system and microvascular reactivity in normotensive subjects with a predisposition to hypertension
    2000 ►
  34. Maver J; Accetto R; Štrucl M; Derganc F
    Altered activity of autonomic nervous system on heart and microcirculation in normotensive subjects with a family history of hypertension
    2001 ►
  35. Braunwald E; Drinovec I; Horvat M; Krivec B; Markež J; Parežnik R; Pehnec Z; Resman J; Šifrer F; Skale R; Trinkaus D; Voga G
    Intravenous NPA for the treatment of infarcting myocardium early: in TIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
    2000 ►
  36. De Backer G; Ambrosio GB; Amouyel P; Cokkinos D; Deckers J; Erhardt L; Graham I; Keber I; Škof E; Špan M
    Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro heart survey programme
    2001 ►
  37. Pust B; Šebenik M; Pavčnik D; Šurlan M
    Long-term improvement of segmental left ventricular hypokinesia after successful PTCA
    1989 ►
  38. Zorc M; Porenta-Vraspir O; Stojšić Ð; Coer A; Zorc R; Radovanović N
    The value of morphometric analysis in the differential diagnosis of dilated cardiomyopathy
    1989 ►
  39. Keber D; Keber I
    Efficacy of exercise training in patients after myocardial infarction taking beta blockers
    1989 ►
  40. Pust B; Šebenik M; Zorc M; Porenta O
    Effects of immunosuppressive treatment of active myocarditis in primary myocardial disease
    1989 ►
  41. Batič M; Žemva A; Žemva Ž
    Insulin and left ventricular mass index in borderline hypertension
    1993 ►
  42. Pust B; Šurlan M
    Pre-PTCA detection of chronic but reversible postishemic myocardial dysfunction by nicardipine
    1993 ►
  43. Pust B; Šebenik M; Zorc M; Porenta O
    Follow-up of active myocarditis in primary myocardial disease with and without immunosuppressive therapy
    1991 ►
  44. Pust B; Šurlan M; Šebenik M
    Improved contraction of "hibernating" myocardium after PTCA of related arterial stenosis
    1990 ►
  45. Pust B; Šurlan M; Rutar V
    Contraction of post-stenotic myocardial segments immediately and late after successful percutaneous transluminal coronary angioplasty
    1995 ►
  46. Šinkovec M; Rakovec P; Zorman D; Antolič G; Grad A
    Exertional syncope in a patient with aortic stenosis and right coronary artery disease
    1995 ►
  47. Pust B; Šebenik M; Obrez I
    Prevention of pacing-induced silent myocardial ischaemia by nifedipine in coronary heart disease
    1988 ►
  48. Rezaković DE; Pavičić L; Majačić M
    A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris
    1988 ►

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko